Share Twitter LinkedIn Facebook Email David R. Gandara, MD, explains whether Keynote 189 impacted view of PDL-1 expression and patient selection at Annual Meeting 2018. Advertisement
ASCO 2025: Lung Cancer Immunotherapy Breakthroughs from the Immuno-Oncology Symposium Lung Cancer Treatment 4 Mins Read